Delivery Order SPE2DB24D1201-SPE2DB24FJAUR

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is an order valued at $5,270.78 for the delivery of BIKTARVY 50-200-25 mg Tablets. The contract was awarded by the Defense Logistics Agency (DLA) and is a Firm Fixed Price Delivery Order with a completion date of July 17, 2024. This order is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, including military treatment...
This federal contract award, valued at $9,180.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a prescription pharmaceutical product, with an ultimate completion date of September 30, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award, valued at $152,581.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part of...
This federal contract award is for a $8,694.35 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET in quantities of 30 tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $7,583.53 awarded by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with the company. The contract covers the procurement of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with an ultimate completion date of October 29, 2024. The contract is a Firm Fixed Price arrangement and does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S. The $26,474.80 firm-fixed-price delivery order contract has an ultimate completion date of September 3, 2024. Amerisourcebergen, through its Corporate Office Division, will provide these essential medical supplies to support military treatment programs and federal healthcare providers...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,739.83 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $4,751.24 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, with a period of performance ending on August 5, 2024. The contract does not have any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $57,878.78 for the supply of BIKTARVY 50-200-25 MG TABLET medication. The contract has a completion date of July 2, 2024 and was awarded on July 1, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $7,482.20 for the supply of BIKTARVY 50-200-25 MG TABLET medication. The contract was awarded by the Defense Logistics Agency (DLA), a major defense agency, and has an ultimate completion date of September 11, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical program, valued at up to $999,999,999 through December 2025,...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJAUR
    Delivery Order

This federal contract award is a delivery order with a firm fixed price of $8,313.80 awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a completion date of August 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, supporting various agency healthcare needs, particularly for military treatment facilities and veterans' hospitals. The company holds several Indefinite Delivery Contracts (IDCs) with agencies such as the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to provide a broad range of essential medical commodities. This specific award does not have a set-aside designation.

Generated 11/1/24, 9:44 AM